Article
FAP+ cells restrict antibody drug delivery and promote an immunosuppressive environment in head and neck squamous cell carcinoma.
2025-03-25
Abstract excerpt
<title>Abstract</title> <p>Background Antibody-based therapies (such as anti-EGFR and anti-PD1/L1 agents) have altered the landscape of cancer treatment to improve patient outcomes in formerly unresponsive tumor types. However, this robust response is not ubiquitous for all patients or cancer subtypes. Head and neck squamous cell carcinoma continues to have reduced response in many patient populations regardless...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 905ed055-cc56-5e4f-993a-4e8faf92ca82
- DOI
- 10.21203/rs.3.rs-6228925/v1
